AlphaFold 3 solved protein-drug interaction problems in 2025, modeling complexes with 95% accuracy—25% better than the average rival method and faster than #4’s superconductor discovery in application speed. This extension to DNA, RNA, and small molecules identified over 200 drug candidates in a year, accelerating timelines from years to months. Concrete data from pharmaceutical partners shows 40% cost reduction per target, a 30% improvement over AlphaFold 2, transforming drug discovery with unprecedented precision.

Comments on "AlphaFold 3 Solves Protein-Drug Interaction Problem"
Create a free account or sign in to join the discussion.
Sign in to join the conversation